Literature DB >> 18592974

[Clinical study of the pars plana Ahmed glaucoma valve implant in refractory glaucoma patients].

Hatsuto Adachi1, Hirokazu Takahashi, Takuhei Shoji, Kazushiro Okazaki, Ken Hayashi, Etsuo Chihara.   

Abstract

PURPOSE: To evaluate the effect of pars plana implantation of the Ahmed glaucoma valve on refractory glaucoma.
METHOD: Five patients (5 eyes) (3 men, 2 women) were fitted with the Ahmed glaucoma valve. Mean age was 51.8 21.3 years, and mean follow-up was 9.4 +/- 2.6 months. Among the 5 eyes studied, 4 eyes were in neovascular glaucoma patients. Of these 4 eyes, 2 eyes were in diabetic retinopathy patients and 2 eyes were in a patient with central retinal vein occlusion. The remaining eye was in a developmental glaucoma patient. As a surgical procedure after pars plana vitrectomy, the inlet tube of the Ahmed glaucoma valve was placed in the posterior chamber. RESULT: The mean preoperative IOP of 46.8 +/- 15.7 mmHg (30-64 mmHg) under maximum tolerable medication was reduced to 16.0 +/- 2.0 mmHg (14-19 mmHg) after surgery. Postoperative visual acuity improved in 3 eyes, and the mean visual acuity in these eyes improved from 0.05 +/- 0.09 (sl.-0.07) to 0.17 +/- 0.3(0-0.7). A reduction in visual acuity was observed in 2 eyes; in one, due to retinal detachment, and in the other, due to transient high IOP and vitreous hemorrhage. The visual acuity improved in 60% of patients and the IOP controlled in 80% of patients.
CONCLUSION: The implantation of the Ahmed glaucoma valve for refractory glaucoma was effective in our study.

Entities:  

Mesh:

Year:  2008        PMID: 18592974

Source DB:  PubMed          Journal:  Nippon Ganka Gakkai Zasshi        ISSN: 0029-0203


  1 in total

1.  Baerveldt or Ahmed glaucoma valve implantation with pars plana tube insertion in Japanese eyes with neovascular glaucoma: 1-year outcomes.

Authors:  Masayo Suda; Hideo Nakanishi; Tadamichi Akagi; Tomoaki Murakami; Kiyoshi Suzuma; Kenji Suda; Takanori Kameda; Satoshi Morooka; Hanako Ohashi Ikeda; Akitaka Tsujikawa
Journal:  Clin Ophthalmol       Date:  2018-11-28
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.